Literature DB >> 20159002

Modified natural cycle IVF and mild IVF: a 10 year Swedish experience.

Arthur Aanesen1, Karl-Gösta Nygren, Lars Nylund.   

Abstract

Modified natural cycle IVF (mnc-IVF) or mild IVF (m-IVF) was offered to selected patients between 1996 and 2007; 43 patients during 129 cycles were treated with mnc-IVF and 145 couples during 250 cycles were treated with m-IVF. Comparison with outcome from conventional IVF cycles during the same time period and in the same clinic was performed. Although 53.5 and 39.6% of started cycles respectively never reached embryo transfer, the ongoing pregnancy rates per embryo transfer were 26.7% for mnc-IVF and 27.2% for m-IVF. During the same time period, cancellation rate for conventional IVF was 13.7% and the ongoing pregnancy rate per embryo transfer was 34.3%. For patients > or =38years of age, the ongoing pregnancy rate per embryo transfer was 17.5% in the m-IVF group. None of the patients aged > or =38years in the mnc-IVF group achieved an ongoing pregnancy. For patients treated with conventional IVF, the > or =38years of age pregnancy rate per embryo transfer was 27.0%. Costs of medication for m-IVF and mnc-IVF were 96.3 and 97.5% less than for the least expensive conventional IVF cycle respectively. Pregnancy rates per embryo transfer are acceptable for these treatment modalities, the cost for medication is low, risks for complications are dramatically reduced, and the treatments may be more psychologically acceptable to the patients. Copyright (c) 2009 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20159002     DOI: 10.1016/j.rbmo.2009.10.017

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  8 in total

1.  Free vitamin D does not vary through the follicular phase of the menstrual cycle.

Authors:  J M Franasiak; X Wang; T A Molinaro; K Green; W Sun; M D Werner; C R Juneau; R T Scott
Journal:  Endocrine       Date:  2016-04-06       Impact factor: 3.633

2.  Why more is less and less is more when it comes to ovarian stimulation.

Authors:  Zeev Blumenfeld
Journal:  J Assist Reprod Genet       Date:  2015-10-19       Impact factor: 3.412

3.  Preliminary proteomic analysis on the alterations in follicular fluid proteins from women undergoing natural cycles or controlled ovarian hyperstimulation.

Authors:  Yan-Ting Wu; Yan Wu; Jun-Yu Zhang; Ning-Ning Hou; Ai-Xia Liu; Jie-Xue Pan; Jie-Yang Lu; Jian-Zhong Sheng; He-Feng Huang
Journal:  J Assist Reprod Genet       Date:  2015-01-18       Impact factor: 3.412

4.  Live birth following serial vitrification of embryos and PGD for fragile X syndrome in a patient with the premutation and decreased ovarian reserve.

Authors:  Dan Nayot; Jin Tae Chung; Weon-Young Son; Assangla Ao; Mark Hughes; Michael H Dahan
Journal:  J Assist Reprod Genet       Date:  2013-09-06       Impact factor: 3.412

Review 5.  Effectiveness of semen washing to prevent human immunodeficiency virus (HIV) transmission and assist pregnancy in HIV-discordant couples: a systematic review and meta-analysis.

Authors:  Maryam Zafer; Hacsi Horvath; Okeoma Mmeje; Sheryl van der Poel; Augusto E Semprini; George Rutherford; Joelle Brown
Journal:  Fertil Steril       Date:  2015-12-11       Impact factor: 7.329

6.  Exogenous gonadotropins do not increase the blood-follicular transportation capacity of extra-ovarian hormones such as prolactin and cortisol.

Authors:  Michael von Wolff; Sophie Schneider; Zahraa Kollmann; Benedicte Weiss; Nick A Bersinger
Journal:  Reprod Biol Endocrinol       Date:  2013-09-04       Impact factor: 5.211

7.  Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterine insemination with controlled ovarian hyperstimulation.

Authors:  A J Bensdorp; R I Tjon-Kon-Fat; P M M Bossuyt; C A M Koks; G J E Oosterhuis; A Hoek; P G A Hompes; F J M Broekmans; H R Verhoeve; J P de Bruin; R van Golde; S Repping; B J Cohlen; M D A Lambers; P F van Bommel; E Slappendel; D Perquin; J M Smeenk; M J Pelinck; J Gianotten; D A Hoozemans; J W M Maas; M J C Eijkemans; F van der Veen; B W J Mol; M van Wely
Journal:  BMJ       Date:  2015-01-09

8.  FSH dose to stimulate different patient' ages: when less is more.

Authors:  Edson Borges; Bianca F Zanetti; Amanda S Setti; Daniela Paf Braga; Rita de Cássia S Figueira; Assumpto Iaconelli
Journal:  JBRA Assist Reprod       Date:  2017-12-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.